JP Morgan Chase’s EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant EQHA.U Stock Holding History

JP Morgan Chase’s Portfolio EQHA.U Stock Details EQHA.U Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-130,323	Closed	-$1.31M	–	7229
2021 Q4	$1.31M	Hold	130,323	–	–	﹤0.01%	4187
2021 Q3	$1.3M	Hold	130,323	–	–	﹤0.01%	4109
2021 Q2	$1.3M	Sell	130,323 -38,377	-23%	-$384K	﹤0.01%	4119
2021 Q1	$1.67M	Buy	+168,700	New	+$1.71M	﹤0.01%	3850

Other funds holding EQHA.U

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

BCM

Basso Capital Management Stamford, Connecticut $163M AUM 21.95% 1-Year Est. Return

Calamos Advisors Naperville, Illinois $28.2B AUM 21.78% 1-Year Est. Return

CIM

Cowen Investment Management New York $12M AUM 1.47% 1-Year Est. Return

MFM

MHR Fund Management New York $1.37B AUM 68.35% 1-Year Est. Return

Wealthspring Capital West Harrison, New York $448M AUM 8.38% 1-Year Est. Return

FTCM

First Trust Capital Management Chicago, Illinois $1.9B AUM 58.39% 1-Year Est. Return

SIA

Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.73% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

MTCM

Mint Tower Capital Management Amsterdam, Netherlands $1.12B AUM 19.06% 1-Year Est. Return

JP Morgan Chase's EQHA.U Position: Q1 2022 in Review

JP Morgan Chase sold out of EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant (EQHA.U) in Q1 2022, closing a stake of 130,323 shares — an estimated $1.31M sold.

JP Morgan Chase first reported a position in EQHA.U in Q1 2021 and held it in 4 quarters. The position peaked at $1.67M in Q1 2021. 17 funds tracked by Wall St. Rank hold EQHA.U as of Q1 2022.

JP Morgan Chase reported no remaining EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant position as of Q1 2022 after selling out during the quarter.
JP Morgan Chase sold 130,323 EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant shares in Q1 2022, an estimated $1.31M.
JP Morgan Chase first reported a position in EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant in Q1 2021 and held it in 4 quarters.
JP Morgan Chase's EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant position peaked at $1.67M in Q1 2021.
17 funds tracked by Wall St. Rank held EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant as of Q1 2022.

Based on JP Morgan Chase's 13F filing for Q1 2022, filed 11 May 2022.